Dr. Niclas Stiernholm has decades of executive experience in the biotechnology industry, most recently as President and Chief Executive Officer of Trillium Therapeutics. Under his direction and leadership Trillium grew from one to 65 employees, raised over $200 million in the capital markets, and transitioned from a discovery-based academic spin...
Roles at Vasomune Therapeutics
My work style
How I prefer to work
Qualities I value in my colleagues
Sign up to see more about the team at Vasomune Therapeutics
My pet peeves
My communication style